Navigation Links
New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study
Date:10/6/2008

Data from SONIC Trial Showed REMICADE Therapy is More Likely to Induce

Steroid-Free Remission and Mucosal Healing Compared with Standard

Immunomodulator, Azathioprine

ORLANDO, Fla., Oct. 6 /PRNewswire/ -- Data presented for the first time from the Phase 3b Study of Patients with Crohn's Disease Naive to Immunomodulators and Biologic Therapy (SONIC) may provide new insights into the approach to care of patients with moderate to severe Crohn's disease. According to findings from the SONIC trial, a significantly greater proportion of patients with moderate to severe Crohn's disease receiving REMICADE(R) (infliximab), either in combination with azathioprine or as monotherapy, experienced steroid-free remission and mucosal healing compared with patients receiving azathioprine alone. Azathioprine is not approved by the U.S. Food and Drug Administration (FDA) for the treatment of Crohn's disease; however, it is widely used by gastroenterologists and other physicians in the United States to treat patients with Crohn's disease. Azathioprine is approved for the treatment of Crohn's disease in some countries outside the United States. Investigators reported that at week 26, 57 percent of patients receiving REMICADE combination therapy and 44 percent of patients receiving REMICADE monotherapy achieved steroid-free remission, the primary endpoint of the study, compared with 31 percent of patients receiving azathioprine alone (P < 0.001 REMICADE with azathioprine vs. azathioprine monotherapy; P = 0.009 REMICADE monotherapy vs. azathioprine monotherapy; P = 0.022 REMICADE with azathioprine vs. REMICADE monotherapy).

"Findings from the SONIC trial have the potential to challenge the treatment protocol for Crohn's disease as these data show that introducing REMICADE earlier may result in more patients achieving steroid-free remission and complete mucosal healing," said Dr. Jean-Frederic Colombel, Professor of Hepatogastroenterology
'/>"/>

SOURCE Centocor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. More Findings on Gene Involved in Childhood Asthma
2. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
3. VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer
4. Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
5. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
6. FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
7. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
8. Study Findings Show Infection Control Intervention Helps Keep Kids in School
9. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
10. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
11. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank Pharmaceuticals, ... for the treatment of Hepatitis B virus (HBV) ... of a $22 million financing. Funds from this ... a novel, broad spectrum antiviral agent derived from ... hybrid (SMNH) chemistry platform, into Phase II clinical ...
(Date:2/26/2015)... 2015  Lyric Pharmaceuticals Inc. today announced the initial ... million. The financing, co-led by RiverVest Venture Partners, Sante ... Venture Partners. Lyric is a clinical-stage ... , M.D., M.B.A., President & Chief Executive Officer and ... In 2014, Lyric closed a seed financing round of ...
(Date:2/26/2015)... 2015  CSSi, ( www.CSSiEnroll.com ) the leader ... industry, is pleased to announce the recent appointment ... Manager, adding significant value and expertise to our ... Karen is an accomplished, ... successfully lead the navigation of the program life ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Completes $22 Million Financing 2CSSi's Continued Growth Brings Talented New Hire - Karen Welch Welcomed as Project Manager 2
... IDM Pharma, Inc.,(Nasdaq: IDMI ) today ... for Medicinal Products for Human Use (CHMP) and ... 25th, following the,CHMP,s September meeting where CHMP considered ... for the,treatment of patients with non-metastatic, resectable osteosarcoma, ...
... Preventing Possibly Life-Threatening,Condition During Air Travel, ALEXANDRIA, ... (APTA) supports the recent "Call to Action" by,Acting ... reduce the number of,cases of deep vein thrombosis ... According to Susan Scherer, PT, PhD, associate professor ...
Cached Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 3
(Date:2/27/2015)... The Radiology Business Management Association ... class of Fellows — one of the most highly ... , Since 2009, the RBMA Fellowship program has ... members to the Association and the profession. Fellow of ... Fellow candidate must meet a very high standard for ...
(Date:2/27/2015)... Leading massage chair retailer Emassagechair.com is known ... month they take a look at leading issues and help ... In the month of March they will be recognizing National ... by bringing awareness to the time change that occurs as ... start on March 2nd, and last until March 8th when ...
(Date:2/27/2015)... to a Feb. 12, 2015 news release by Verastem, ... by killing cancer stem cells, has received orphan drug designation ... in the treatment of mesothelioma.* According to the release, orphan ... development of drugs for the treatment of rare diseases. ... Melinda Helbock, Founder of The Law Office of Melinda J. ...
(Date:2/27/2015)... Atlanta, GA (PRWEB) February 27, 2015 ... firm, Martin Ventures, is collaborating with the Atlanta-based ... accelerate the adoption of Jvion’s advanced predictive capabilities ... predictive analytics company that identifies and prevents financial ... growing need for predictions that help prevent patient ...
(Date:2/27/2015)... Santa Cruz, CA (PRWEB) February 27, 2015 ... Opal Gas Processing Plant in Lincoln County, Wyoming. ... the area in preparation for interstate natural gas pipeline ... the natural gas., The Opal plant initially began operations ... expansions to serve growing natural gas production in Wyoming. ...
Breaking Medicine News(10 mins):Health News:RBMA Issues Call for Fellowship Applicants 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 3Health News:Clean Water Systems Supplies Advanced Chlorine Disinfection Skid for Wyoming Gas Plant 2
... by the bird flu threat has resulted in poultry products ... capital. One can see that in Gazipur wholesale market chickens ... ,Only those chickens that were certified by the veterinary ... whereas those that were uncertified was available for a mere ...
... blood samples, taken from the people of Nandurbar district, is ... virus had spread to humans, even as the culling of ... ,Officials said the massive culling exercise in the region that ... to be completed by early Thursday. ,India's first ...
... ever-cervical cancer vaccine, Gardasil is expected to be launched ... 24 years of age. // Soon, men might also ... infecting their sexual partners and to protect themselves against ... under experimental phase, for demonstration of cervical cancer prevention. ...
... announced the approval of a new antifungal drug, for ... new drug called Eraxis, // is indicated in the ... ,The improved performance of Eraxis compared to ... have supported the approval. The drug can also be ...
... health problem of having too many ailing hearts, making it ... the bloc’s members, a whopping 169 billion euros in 2003, ... look at the annual statistics, but watch your heart before ... 230 euros on an average on Healthcare costs, per person. ...
... Inc. (OTCBB:MDLH) Needle– Free Injection System, designed specifically to ... toward establishing itself as a valuable instrument in the ... animals. With its patented ability to adjust pressure and ... the Company in a unique situation especially should there ...
Cached Medicine News:Health News:Delhi Sees Sharp Decline In Chicken Prices 2Health News:Delhi Sees Sharp Decline In Chicken Prices 3Health News:India Awaits Test Results To Confirm The Bird Flu Virus In Humans 2Health News:Men Might Get Their Share of Cervical Cancer Vaccine As Well 2Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 2Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 3
... difficile Panel is an enzyme immunoassay used ... antigen (glutamate dehydrogenase) and toxin A in ... as an aid in the diagnosis of ... of the Triage Microbiology product line, designed ...
ELISA for the detection of C. difficile toxin A in stool specimens...
... CCD cameras provide fast, accurate, reliable and ... quality at an excellent price. , , ... TOMEY TR-4000 Auto Refractor provides highly accurate ... is obtained simply by pushing a button. ...
... SP-3000 covers all needs regarding pachymetry in ... care., ,Compact design, colored touch-screen and "quick ... an "easy-to-use unit.,The wide measurement range from ... the possibility to measure very thin or ...
Medicine Products: